20:39 IST
BSE
Other Announcement
Kimia Biosciences Other Announcement
The company filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ended March 31, 2026.
Kimia Biosciences Ltd
- Share price
- ₹30.77
- Market cap
- ₹145.6 Cr
- Revenue (annual)
- ₹114.9 Cr
- Net profit (annual)
- ₹7.43 Cr
- P/E (TTM)
- 20.3×Sector 50.4×
- Promoter holding
- 74.94%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
16:26 IST
BSE
Annual General Meeting
Kimia Biosciences Annual General Meeting
Kimia Biosciences Limited has submitted its notice for the 33rd Annual General Meeting scheduled for September 28, 2026, along with the Annual Report for FY 2025-26.
18:47 IST
BSE
Board Meeting Outcome
Kimia Biosciences Board Meeting Outcome
Kimia Biosciences' board meeting outcome includes director appointments, approval of the 33rd AGM notice, and increased borrowing/investment limits. The board also adopted the annual report.
16:53 IST
BSE
Financial Results
Kimia Biosciences Q1 FY27 Results: Net Profit ₹0.4 Cr, Down 33.3% YoY
Kimia Biosciences Ltd reported revenue from operations of ₹20.7 Cr (-12.3% YoY) and net profit of ₹0.4 Cr (-33.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.4 Cr · -33.3% YoY
17:28 IST
BSE
Financial Results
Kimia Biosciences Q4 FY26 Results: Net Profit ₹0.4 Cr, Down 80.0% YoY
Kimia Biosciences Ltd reported revenue from operations of ₹27.2 Cr (-28.8% YoY) and net profit of ₹0.4 Cr (-80.0% YoY) for Q4 FY26.
- Key figure
- Net profit ₹0.4 Cr · -80.0% YoY